Showing 25–32 of 32 peptides in Weight Loss
A GLP-1 receptor agonist primarily used for weight management and blood sugar control.
- GLP‑1 receptor agonist studied for substantial and sustained weight loss in obesity
- Improves glycemic control and reduces cardiovascular and metabolic risk factors
- Acts on appetite centers and slows gastric emptying to enhance satiety
- Muscle Recovery
- Sleep & Mood
- +1
A growth hormone releasing hormone analog.
- GHRH analog studied for stimulating endogenous growth hormone secretion
- May support lean body mass, recovery, and sleep quality in GH‑deficient states
- Investigated as a physiologic alternative to exogenous GH therapy
- Weight Loss
- Heart & Vascular Health
A metabolic peptide studied for energy expenditure.
- Selective thyroid hormone receptor‑beta agonist researched for increasing energy expenditure
- May improve lipid profiles, fatty liver parameters, and body composition in models
- Investigated for obesity and metabolic syndrome without classical hyperthyroid effects
A dual-agonist peptide researched for potent obesity and metabolic control.
- Weight Loss
- Muscle Recovery
- +1
A stabilized GHRH analog studied for GH enhancement.
- GHRH analog studied for reducing visceral adipose tissue, especially in HIV‑associated lipodystrophy
- Increases endogenous GH and IGF‑1 while largely preserving insulin sensitivity
- Investigated for body‑composition improvement and cardiometabolic risk reduction
A monoamine reuptake inhibitor studied for weight loss.
- Triple monoamine reuptake inhibitor researched for robust appetite suppression and weight loss
- Increases synaptic dopamine, norepinephrine, and serotonin to enhance satiety signaling
- Investigated for preserving resting energy expenditure and limiting post‑diet weight regain
A hypothalamic peptide studied for thyroid axis regulation.
- Hypothalamic tripeptide studied for stimulating TSH release from the pituitary
- May support thyroid hormone production and metabolic regulation in deficiency states
- Investigated for diagnostic testing of pituitary–thyroid axis integrity
A dual incretin peptide studied for powerful metabolic regulation.
- Dual GIP/GLP‑1 receptor agonist researched for powerful glucose lowering and weight loss
- Improves beta‑cell function and insulin sensitivity beyond GLP‑1 agonists alone
- Investigated for type 2 diabetes, obesity, and cardiometabolic risk reduction
